492 related articles for article (PubMed ID: 9072202)
1. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
Saló J; Caballería L; Bruguera M; Parés A; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
[TBL] [Abstract][Full Text] [Related]
2. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
Taylor SL; Dean PJ; Riely CA
Am J Surg Pathol; 1994 Jan; 18(1):91-9. PubMed ID: 8279631
[TBL] [Abstract][Full Text] [Related]
3. [Atypical primary biliary cirrhosis or autoimmune cholangitis?].
Primo J; Miralles A; Ferrando J; Albert A; Julve R; Gómez A; García L
Gastroenterol Hepatol; 1999 Dec; 22(10):505-9. PubMed ID: 10650665
[TBL] [Abstract][Full Text] [Related]
4. Antimitochondrial antibody-negative primary biliary cirrhosis.
Lacerda MA; Ludwig J; Dickson ER; Jorgensen RA; Lindor KD
Am J Gastroenterol; 1995 Feb; 90(2):247-9. PubMed ID: 7847294
[TBL] [Abstract][Full Text] [Related]
5. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune cholangitis within the spectrum of autoimmune liver disease.
Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
Hepatology; 2000 Jun; 31(6):1231-8. PubMed ID: 10827147
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune cholangitis or seronegative biliary cirrhosis: report of one case].
Ndongo S; Mbengue M; Dia D; Seck SM; Ka MM; Moreira Diop T
Dakar Med; 2008; 53(2):127-30. PubMed ID: 19634547
[TBL] [Abstract][Full Text] [Related]
9. [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
Tunis Med; 2003 Jul; 81(7):499-504. PubMed ID: 14534962
[TBL] [Abstract][Full Text] [Related]
10. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
11. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
12. [Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid].
Wirth HP; Zala G; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):750-4. PubMed ID: 7740290
[TBL] [Abstract][Full Text] [Related]
13. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
14. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
[TBL] [Abstract][Full Text] [Related]
15. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy.
Zukowski TH; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1998 Jun; 93(6):958-61. PubMed ID: 9647028
[TBL] [Abstract][Full Text] [Related]
17. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
Kayacetin E; Köklü S; Temuçin T
Dig Liver Dis; 2004 Jun; 36(6):419-22. PubMed ID: 15248383
[TBL] [Abstract][Full Text] [Related]
18. Primary biliary cirrhosis.
Kaplan MM; Gershwin ME
N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
[No Abstract] [Full Text] [Related]
19. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
Zeng Z; Han YK; Zhang XF; Geng H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
[TBL] [Abstract][Full Text] [Related]
20. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
